Kyung Dong Pharmaceutical Company Ltd - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Kyung Dong Pharmaceutical Company Ltd Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Kyung Dong Pharmaceutical Company Ltd. The Company's principal activities are manufacturing and selling of pharmaceutical products for multiple therapeutic fields. The Company's two main product groups include finished compounds, including acetaminophen, roxithromycin, acyclovir, ofloxacin, dihydroergocristine methanesulfonate, metformin, levosulpiride, dihydroxyaluminum allantoinate, domperidone maleate, ambroxol and other products, and raw bulk materials, comprised of difemerine hydrochloride, tiropramide hydrochloride, cilostazol, aceclofenac, levofloxacin, nizatidine and rebamipide. In addition, the Company is engaged in the sale of animal drugs and sports related products, among others. Kyungdong Pharmaceutical's products are exported to international customers in Brazil, Cambodia, Chile, Colombia, Costa Rica, India, Japan, Jordan, Pakistan, the Republic of Yemen, Spain, Sudan, Syria and Vietnam.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report